瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RMD 瑞思迈

盘前交易 04-19 05:45:11 EDT

177.61

+3.78

+2.17%

最高179.80	最低176.33	成交量158.31万
今开177.40	昨收173.83	日振幅2.00%
总市值260.89亿	流通市值258.33亿	总股本1.47亿
成交额2.81亿	换手率1.09%	流通股本1.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RMD","market":"US","secType":"STK","nameCN":"瑞思迈","latestPrice":177.61,"timestamp":1713470400000,"preClose":173.83,"halted":0,"volume":1583061,"delay":0,"floatShares":145449000,"shares":146886683,"eps":6.039863,"marketStatus":"盘前交易","marketStatusCode":1,"change":3.78,"latestTime":"04-19 05:45:11 EDT","open":177.4,"high":179.8,"low":176.33,"amount":281224422.74478,"amplitude":0.019962,"askPrice":217.15,"askSize":100,"bidPrice":164.1,"bidSize":11,"shortable":3,"etf":0,"ttmEps":6.039863,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713533400000},"adr":0,"adjPreClose":177.61,"adrRate":0,"dividendRate":0.01036,"postHourTrading":{"tag":"盘后","latestPrice":177.62,"preClose":177.61,"latestTime":"19:04 EDT","volume":16634,"amount":2954369.69,"timestamp":1713481450153},"volumeRatio":1.472127426035429},"requestUrl":"/m/hq/s/RMD","defaultTab":"news","newsList":[{"id":"2428302266","title":"BUZZ-礼来制药降低睡眠呼吸暂停严重程度后，瑞思迈在澳大利亚证券交易所上市的股票下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2428302266","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428302266?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:12","pubTimestamp":1713402725,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月18日 - ** 在澳大利亚证券交易所上市的瑞思迈  股价下跌多达6.3%，至27.050澳元，将创下自2023年8月7日以来最糟糕的一天--如果跌势得以维持的话。 ** 礼来  周三在 (link)，其减肥药物有助于减少与睡眠呼吸暂停有关的不规则呼吸发作--这是一种常见的睡眠相关疾病。 ** RMD 生产用于治疗睡眠呼吸暂停的设备，因此引发了竞争担忧 ** 股价跌至 3 月 4 日以来最低点 ** 在澳大利亚证券交易所上市的股票在基准指数中跌幅最大 ** 截至上次收盘，今年股价已上涨 13.5","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428344172","title":"BUZZ-礼来减肥药在睡眠呼吸暂停试验中获得成功后，瑞思迈业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2428344172","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428344172?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:38","pubTimestamp":1713364728,"startTime":"0","endTime":"0","summary":" (更新)    4月17日 - ** 在礼来  的减肥药在睡眠呼吸暂停患者身上的试验取得成功后，CPAP机制造商瑞思迈  的股价下跌3.68%，至178.06美元。** RMD和INSP生产用于治疗睡眠呼吸暂停的医疗设备，睡眠呼吸暂停是一种潜在的严重睡眠障碍，患者呼吸不规律** 礼来公司的减肥药 tirzepatide 有助于减少  阻塞性睡眠呼吸暂停患者的不规则呼吸频率** 券商摩根大通表示，它认为这种药物的减重效果不足以取代 CPAP 或 Inspire，而是可以将替瑞帕肽与这些疗法一起用于治疗 OSA。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428467653","title":"瑞思迈盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428467653","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428467653?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:47","pubTimestamp":1713361629,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时47分，瑞思迈股票出现波动，股价大幅下挫5.01%。截至发稿，该股报175.59美元/股，成交量75.2714万股，换手率0.51%，振幅4.17%。瑞思迈股票所在的医疗设备行业中，整体跌幅为0.53%。其相关个股中，Innovative Eyewear, Inc.、Predictive Oncology Inc.、Singular Genomics Systems, Inc.涨幅较大，Innovative Eyewear, Inc.、Atrion、瑞思迈较为活跃，换手率分别为2.51%、0.54%、0.51%，振幅较大的相关个股有中进医疗、Innovative Eyewear, Inc.、Repligen Corporation，振幅分别为11.52%、9.49%、5.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214709792141e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417214709792141e9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428314811","title":"BUZZ-礼来减肥药在睡眠呼吸暂停试验中获得成功后，ResMed、Inspire Medical业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2428314811","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428314811?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:52","pubTimestamp":1713354727,"startTime":"0","endTime":"0","summary":"    4月17日 - ** 礼来  减肥药在睡眠呼吸暂停患者试验中获得成功后，瑞思迈  、Inspire Medical  股价盘前下跌** 瑞思迈股价下跌6.6%至172.60美元，Inspire Medical股价下跌7.7%至204.50美元** 在两项后期试验中，礼来公司的减肥药物帮助阻塞性睡眠呼吸暂停患者减少了  不规则呼吸的频率，平均减少幅度高达 63** LLY 股价上涨 1.2%，至 755.72 美元** 瑞思迈和Inspire Medical生产用于治疗睡眠呼吸暂停的医疗设备，睡眠呼吸暂停是一种潜在的严重睡眠障碍，患者的呼吸会反复停止和开始。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417794318","title":"瑞思迈盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417794318","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417794318?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:28","pubTimestamp":1709828923,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日00时28分，瑞思迈股票出现波动，股价大幅拉升5.00%。截至发稿，该股报193.49美元/股，成交量46.9456万股，换手率0.32%，振幅2.46%。瑞思迈股票所在的医疗设备行业中，整体涨幅为1.36%。其相关个股中，Nyxoah Sa、Ekso Bionics Holdings, Inc.、Stereotaxis, Inc.涨幅较大，Avinger, Inc.、Sharps Technology Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为101.51%、1.85%、1.33%，振幅较大的相关个股有Avinger, Inc.、Sharps Technology Inc.、Nexgel, Inc，振幅分别为30.54%、15.90%、13.51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800284487e76ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030800284487e76ff8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417483410","title":"BUZZ-麦格理称 CSL 和 Resmed 最受澳大利亚医疗保健公司青睐","url":"https://stock-news.laohu8.com/highlight/detail?id=2417483410","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417483410?lang=zh_cn&edition=full","pubTime":"2024-03-05 09:02","pubTimestamp":1709600573,"startTime":"0","endTime":"0","summary":"    3月5日 - ** 麦格理分析师选择澳大利亚生物制药巨头 CSL Ltd    和规模较小的竞争对手 Resmed    作为首选，原因是新产品管道和运营效率的潜在贡献。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2407989648","title":"BUZZ-飞利浦新型睡眠呼吸暂停器械在美国的销售在 FDA 达成协议后将被停止，瑞思迈因此上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2407989648","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2407989648?lang=zh_cn&edition=full","pubTime":"2024-01-29 23:17","pubTimestamp":1706541435,"startTime":"0","endTime":"0","summary":" (更新)    1月29日 - ** 瑞思迈  股价上涨3.72%，至197.22美元** 荷兰健康科技公司飞利浦  表示，它已与美国食品和药物管理局就其睡眠呼吸暂停设备的同意令条款达成 。** 飞利浦将在未来几年内不再在美国销售  治疗睡眠呼吸暂停的新设备，因为该公司正在努力遵守与美国食品及药物管理局达成的协议- Co.** 同意令主要针对飞利浦Respironics公司在美国的业务运营，并将提供一份改进路线图。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406214142","title":"瑞思迈盘中异动 股价大涨10.61%报190.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406214142","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406214142?lang=zh_cn&edition=full","pubTime":"2024-01-25 22:31","pubTimestamp":1706193090,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日22时31分，瑞思迈股票出现异动，股价快速上涨10.61%。截至发稿，该股报190.00美元/股，成交量5254股，换手率0.00%，振幅0.26%。瑞思迈股票所在的医疗设备行业中，整体涨幅为0.96%。其相关个股中，瑞思迈、Nyxoah Sa、Nexgel Inc C/Wts 01/12/2026 涨幅较大，Bionano Genomics Inc、Microbot Medical Inc、Nyxoah Sa较为活跃，换手率分别为0.15%、0.06%、0.03%，振幅较大的相关个股有Pulse Biosciences Inc、Nanostring Technologies Inc、Bionano Genomics Inc，振幅分别为3.56%、2.59%、2.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012522313081e38cd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012522313081e38cd7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406219303","title":"BUZZ-瑞思迈第二季度业绩向好，券商上调 PT 值，公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2406219303","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406219303?lang=zh_cn&edition=full","pubTime":"2024-01-25 22:23","pubTimestamp":1706192582,"startTime":"0","endTime":"0","summary":"    1月25日 - ** 呼吸设备制造商瑞思迈  股价盘前上涨9.7%至188.41美元 ** 周三收盘后，该公司公布的  第二季度营收和利润均高于华尔街预期，原因是用于治疗睡眠呼吸暂停的呼吸设备需求强劲。** 券商杰富瑞重申该股 \"持有 \"评级，但将预测价格从 158 美元上调至 164 美元，并预测 RMD 25 财年每股收益为 7.99 美元。** 截至收盘，股价在过去 12 个月中下跌了 24.8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406400747","title":"BUZZ-瑞思迈在澳大利亚证券交易所上市，第二季度业绩喜人，股价接近 6 个月高点","url":"https://stock-news.laohu8.com/highlight/detail?id=2406400747","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406400747?lang=zh_cn&edition=full","pubTime":"2024-01-25 09:05","pubTimestamp":1706144752,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月25日 - ** 在澳大利亚证券交易所上市的瑞思迈  股价上涨6.5%至28.500澳元，创下自2023年8月8日以来的最高水平** 如果涨势保持，股价有望创下自5月1日以来的最佳表现 ** 医疗设备制造商 (link) 报告称，第二季度收入增长 12%，达到 12 亿美元。** 该公司称， (link)，收入增长得益于对用于治疗睡眠呼吸暂停的呼吸设备的强劲需求** 该公司是基准 S&P/ASX 200 指数    中涨幅最大的公司之一 ** 截至上次收盘，该公司股票今年已上涨 5.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406405036","title":"BUZZ-瑞思迈第二季度业绩乐观，股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2406405036","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406405036?lang=zh_cn&edition=full","pubTime":"2024-01-25 07:13","pubTimestamp":1706138038,"startTime":"0","endTime":"0","summary":"    1月24日 - ** 呼吸设备制造商瑞思迈  股价盘后上涨7.7%至185.01美元**  第二季度收入和利润高于华尔街预期，主要得益于治疗睡眠呼吸暂停的呼吸设备需求强劲** RMD 第二季度每股利润为 1.88 美元，高于分析师预计的 1.8 美元，营收为 12 亿美元，高于预计的 11.5 亿美元 - LSEG 数据** 毛利率从 56.5% 下降到 55.1%，主要原因是公司召回含有磁铁的呼吸面罩的相关成本 - RMD** 本月早些时候，美国卫生监管机构将此次召回列为最严重召回。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406995408","title":"睡眠呼吸暂停器械销售强劲，瑞思迈业绩超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2406995408","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2406995408?lang=zh_cn&edition=full","pubTime":"2024-01-25 06:22","pubTimestamp":1706134961,"startTime":"0","endTime":"0","summary":"同时，毛利率从 56.5% 下降到 55.1%，主要原因是公司召回含有磁铁的呼吸面罩的相关费用。根据 LSEG 的数据，分析师预期毛利率为 56%。该公司表示，这些产品将继续在市场上销售，被列为召回的原因是对标签进行了更正。Zepbound或tirzepatide正处于晚期 ，用于治疗阻塞性睡眠呼吸暂停和肥胖症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403273305","title":"BUZZ-ResMed 因 FDA 认定其呼吸设备召回最严重而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2403273305","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403273305?lang=zh_cn&edition=full","pubTime":"2024-01-13 02:44","pubTimestamp":1705085063,"startTime":"0","endTime":"0","summary":"    1月12日 - ** 医疗设备制造商瑞思迈  股价下跌2.4%至173.60美元 ** 美国食品和药物管理局周四晚些时候将  公司生产的某些呼吸面罩的召回列为最严重的召回，因为使用这些面罩可能会造成重大伤亡。** 由于可能对某些医疗设备和植入物产生磁干扰，该公司正在召回部分型号的呼吸面罩 ** RMD于11月20日开始召回程序，目前已在美国召回超过2000万个设备** 美国食品和药物管理局称，有 6 起受伤报告，没有死亡报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402802287","title":"美国 FDA 认定瑞思迈呼吸设备召回最为严重","url":"https://stock-news.laohu8.com/highlight/detail?id=2402802287","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402802287?lang=zh_cn&edition=full","pubTime":"2024-01-12 06:50","pubTimestamp":1705013435,"startTime":"0","endTime":"0","summary":"    路透1月11日 - 美国食品和药物管理局 周四将瑞思迈  生产的某些呼吸面罩的召回列为最严重的召回，因为使用这些面罩可能会造成重大伤亡。美国食品和药物管理局说，瑞思迈召回其部分型号的持续正压通气 面罩AirFit和AirTouch，原因是它们可能对某些医疗设备和植入物产生磁干扰，从而可能破坏它们的功能或位置，造成严重伤害或死亡。FDA 表示，瑞思迈召回这些口罩是为了更新标签并增加更多警告和信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402706131","title":"瑞思迈盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402706131","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402706131?lang=zh_cn&edition=full","pubTime":"2024-01-09 22:53","pubTimestamp":1704812013,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日22时53分，瑞思迈股票出现异动，股价急速拉升5.02%。截至发稿，该股报181.45美元/股，成交量13.5871万股，换手率0.09%，振幅2.95%。瑞思迈股票所在的医疗设备行业中，整体涨幅为0.21%。最近的发展和收购都集中在数字健康上，因为瑞思迈的目标是通过提供临床数据供院外环境中的患者、医疗保健顾问和付款人使用来实现差异化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922533479076a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922533479076a53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402924197","title":"BUZZ-澳大利亚医疗保健股创逾 6 个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2402924197","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402924197?lang=zh_cn&edition=full","pubTime":"2024-01-09 12:55","pubTimestamp":1704776120,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月9日 - ** 澳大利亚医疗保健  指数上涨 2%，创 6 月 14 日以来新高** 如果趋势保持不变，该分项指数有望创下自12月6日以来的最大盘中涨幅。** Resmed   在分指数中涨幅居首，大涨 6.4%**该股也是基准  指数中涨幅第三大的股票 ** RMD 创 8 月 17 日以来新高，有望创下 5 月 1 日以来最大盘中涨幅 ** 子指数中最昂贵的股票 CSL    涨 1.6** AXHJ 去年上涨 2.3%，表现逊于基准指数   ，后者收盘上涨 7.8","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.resmed.com","stockEarnings":[{"period":"1week","weight":-0.0628},{"period":"1month","weight":-0.0798},{"period":"3month","weight":0.0294},{"period":"6month","weight":0.2317},{"period":"1year","weight":-0.2013},{"period":"ytd","weight":0.0325}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ResMed Inc.是一家特拉华州公司，成立于1994年3月。该公司在医疗设备和基于云的软件应用程序的开发、制造、分销和营销方面处于全球领先地位，这些应用程序诊断、治疗和管理呼吸系统疾病，包括睡眠呼吸障碍、慢性阻塞性肺病、神经肌肉疾病和其他慢性疾病。该公司的产品和解决方案旨在改善患者的生活质量，减少慢性病的影响，并降低医疗保健成本，因为全球医疗保健系统继续推动从医院到家庭和低成本环境的护理转移。该公司基于云的数字软件健康应用程序以及设备旨在提供联网护理，以改善患者的治疗效果并提高客户的效率。","yearOnYearQuotes":[{"month":1,"riseRate":0.689655,"avgChangeRate":0.023453},{"month":2,"riseRate":0.551724,"avgChangeRate":0.003068},{"month":3,"riseRate":0.62069,"avgChangeRate":0.019281},{"month":4,"riseRate":0.517241,"avgChangeRate":0.008707},{"month":5,"riseRate":0.642857,"avgChangeRate":0.013771},{"month":6,"riseRate":0.703704,"avgChangeRate":0.044828},{"month":7,"riseRate":0.714286,"avgChangeRate":0.023968},{"month":8,"riseRate":0.586207,"avgChangeRate":0.025601},{"month":9,"riseRate":0.413793,"avgChangeRate":0.016915},{"month":10,"riseRate":0.413793,"avgChangeRate":-0.001014},{"month":11,"riseRate":0.758621,"avgChangeRate":0.034553},{"month":12,"riseRate":0.62069,"avgChangeRate":0.02417}],"exchange":"NYSE","name":"瑞思迈","nameEN":"ResMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞思迈(RMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞思迈,RMD,瑞思迈股票,瑞思迈股票老虎,瑞思迈股票老虎国际,瑞思迈行情,瑞思迈股票行情,瑞思迈股价,瑞思迈股市,瑞思迈股票价格,瑞思迈股票交易,瑞思迈股票购买,瑞思迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞思迈(RMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞思迈(RMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}